ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
Benzinga
NOVEMBER 8, 2022
With its needle-free administration, neffy ® may help eliminate the anxiety and hesitation associated with using an epinephrine injection device. The Company's New Drug Application (NDA) submission for neffy ® is currently under review by the U.S. if Approved. SAN DIEGO, Nov. SAN DIEGO, Nov. Silverback).
Let's personalize your content